HK:1877 Stock Latest News
PremiumCompany AnnouncementsShanghai Junshi Biosciences Advances Monkeypox Vaccine Development Shanghai Junshi Biosciences Announces Change in Shareholder Equity Shanghai Junshi Biosciences Announces 2024 AGM with Strategic Financial Proposals PremiumCompany AnnouncementsShanghai Junshi Biosciences to Participate in STAR Market Briefing Shanghai Junshi Biosciences Appoints New Securities Affairs Representative Shanghai Junshi Biosciences Gains Approval for Toripalimab as First-Line Melanoma Treatment PremiumCompany AnnouncementsShanghai Junshi Biosciences Announces Board Composition and Governance Structure Shanghai Junshi Biosciences Establishes Compliance Committee Shanghai Junshi Biosciences Gains Approval for Toripalimab in Singapore